ASTH Astrana Health Inc. Common Stock

XNAS 37.23 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

ASTH $37.23 —
Key stats
$37.23
Pre-market $37.35 +0.32%
52-Week Range
$18.08 – $51.60
YTD
+47.62%
IV Rank (30D)
78.18
Straddle Price
$6.60
P/C Vol Ratio
0.78
Market Cap
$1.9B
Open
$37.33
Day Range
$37.00 – $38.41
Volume
250,154
Prev Close
$37.45
Fair Value
MODEL: NEUTRAL

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY1.05
Cost of Equity (CAPM)10.73% (VRP-adj)
WACC8.77%
Volatility Risk Premium+89.6pp (IV − HV30), ERP adj +50bps
Effective Tax Rate34.7%
Rev. Growth (YoY, DCF input)+1.7%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.02 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.1B
Return on Equity (TTM)4.9%
Book / Price45.6% — banking bias active (P/B is primary)
Gross Margin (TTM)10.5%
FCF Margin (TTM)2.5%
Debt / Equity1.05
Quality Score0/6 — cyclical/struggling (5y DCF)
Market-Implied Growth+12.3% (reverse-DCF on current price)
SMA 50$37.29 (Market Anchor value)
SMA 20 / Bollinger Mid$37.03
Bollinger Width / SMA2029.1% (drives anchor stability)
Net Debt$0.5B
Market Cap$2B
Peers used for multiples: AMN, OSCR, WAY (filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
8%
20-Day Fair Value
≈ by Nov 25, 2026
$36.99
α -0.6% rank 39%
conviction
39%
40-Day Fair Value
≈ by Dec 24, 2026
$37.20
α -0.1% rank 43%
conviction
2%
60-Day Fair Value
≈ by Jan 22, 2027
$37.31
α +0.2% rank 36%
conviction
8%
MethodImplied PriceWeightDetail
DCF $20.40 42%
DDM (Gordon) n/a 0%
Peer P/E $14.78 10% median 17.7× · 3 peers
Peer EV/EBITDA $30.48 12% median 12.0× · 3 peers
Peer P/B $42.64 16% median 2.5× · 3 peers
Peer P/S $49.77 16% median 0.6× · 3 peers
Market Anchor (SMA50) $37.29 4% stability 4% (BB-width)
Options Expected (B-L 30d) $36.95 0% 9 strikes · skew +0.14
As of 2026-10-27 · updated
About
Industry (SIC)
SERVICES-MANAGEMENT CONSULTING SERVICES (8742) · industry map
Exchange
XNAS
Market Cap
$1.9B
Employees
3,000
List Date
2007-11-26
CIK
0001083446
Next Earnings
2026-11-05 (After-Close)
EPS Forecast
$0.44 (3 est.)
Headquarters
Alhambra, CA
Homepage
https://www.astranahealth.com

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'24'25'26Avg
Jan--14.50%-9.83%2.33%
Feb5.26%-30.04%-8.92%-11.23%
Mar-3.63%17.11%-6.84%2.21%
Apr-11.63%4.39%39.29%10.68%
May11.22%-21.15%7.82%-0.70%
Jun-3.98%1.55%22.91%6.83%
Jul32.04%-4.79%-28.81%-0.52%
Aug-7.33%48.17%6.13%15.66%
Sep22.24%-11.07%-7.85%1.11%
Oct-7.02%10.83%6.65%*3.49%
Nov-20.69%-30.16%---25.43%
Dec-29.64%7.03%---11.30%
Total-25.71%-18.50%4.87%-13.11%
* Only 3 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $37.03
SMA 50: $37.29
SMA 200: $33.66
Current: $37.23
EMA 12: $37.39
EMA 26: $37.17
MACD: 0.2152 | Signal: 0.0730
BULLISH
ADX (14): 13.64
RANGE
+DI: 21.93
−DI: 15.47

Momentum Oscillators

RSI (14): 50.28
NEUTRAL
Stoch %K: 48.63
Stoch %D: 53.14
Williams %R: -58.80

Volume & Volatility

BB Upper: $39.02
BB Lower: $35.03
NEUTRAL
OBV: 21,781,096
Vol SMA 20: 306,671
Vol ROC: -15.07%
ATR: $1.60
True Range: $1.41
HV 20: 37.3%
HV 30: 49.4%
HV 60: 50.0%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 6/10)

Key drivers:

  • Recent positive news headlines from earnings reports and CMS boosts in Medicare payments
  • Strong technical signals, including a potential bullish crossover of the MACD

Primary risks:

  • Volatility may increase as the stock approaches its upper Bollinger Band
  • Potential for profit-taking if the stock fails to break above recent highs

Investment thesis: ASTH has strong fundamental and technical momentum, driven by positive earnings reports and regulatory catalysts. The stock is likely to continue its uptrend, but investors should be cautious of increased volatility and potential profit-taking.

Recent news sentiment impact: The positive sentiment from recent news headlines has contributed significantly to the stock's upward move. Investors are optimistic about the company's prospects and have driven up the stock price accordingly.

Technical Analysis

Trend Direction: Medium-term (1-3 months): Bullish Support/Resistance Levels:

  • Lower Bollinger Band: $32.23
  • Middle Bollinger Band: $37.84
  • Upper Bollinger Band: $43.44
  • SMA 50: $41.13

Momentum Signals:

  • RSI interpretation: Neutral (51.46)
  • MACD signal: Bullish crossover (bearish)
  • Bollinger Bands position: Neutral (squeeze)

Volume Analysis:

  • Volume trend: Low volume, but increasing
  • Institutional interest signals: Moderate institutional buying activity

News & Sentiment Analysis

Recent Headlines Summary: Positive news headlines from earnings reports and CMS boosts in Medicare payments.

Sentiment Assessment: Positive sentiment prevails, driven by recent news headlines.

Catalyst Identification: Upcoming earnings reports, potential for additional regulatory catalysts.

Market Narrative: The positive sentiment is aligned with the technical signals, suggesting a strong uptrend is likely to continue.

Risk & Volatility Assessment

Beta Interpretation: Low risk (beta = 0.70 vs SPY)

Volatility Regime: Current volatility is low compared to historical levels.

Options Market Signals:

  • IV rank: Medium
  • Put/call ratio: Bearish sentiment
  • Unusual activity: Moderate buying pressure in calls

Downside Protection: Support levels at $32.23 and $37.84 may serve as downside protection.

Market Context & Positioning

Sector Performance: ASTH is outperforming the sector (healthcare) and market (SPY).

Institutional Activity: Moderate institutional buying activity suggests support for the stock price.

Correlation Analysis: The stock has a low correlation with the market, indicating a potential trend leader.

Relative Valuation: The stock is trading near its upper Bollinger Band, suggesting it may be overbought.

Key Levels & Action Items

Critical Price Levels:

  • Lower Bollinger Band: $32.23
  • Middle Bollinger Band: $37.84
  • Upper Bollinger Band: $43.44
  • SMA 50: $41.13

Breakout/Breakdown Levels: A breakout above the upper Bollinger Band could signal a continuation of the uptrend.

Time-Sensitive Catalysts: Upcoming earnings reports and potential regulatory catalysts may drive the stock price.

Risk Management: Investors should consider setting stop-loss levels at $37.84 or below to manage risk. Position sizing considerations include limiting exposure to 2-3% of overall portfolio.

Generated
Earnings History
7 of 11 under expected move
Avg Expected Move
13.23%
Avg Actual Move
12.31%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-02-27 After-Close 11.09% 0.53% 0.05x Within
2024-05-07 After-Close 11.68% 0.42% 0.04x Within
2024-08-07 After-Close 9.98% 1.06% 0.11x Within
2024-11-07 After-Close 7.32% 20.51% 2.80x Exceeded
2025-02-27 After-Close 15.35% 26.82% 1.75x Exceeded
2025-05-08 After-Close 11.29% 11.14% 0.99x Within
2025-08-07 After-Close 14.10% 30.85% 2.19x Exceeded
2025-11-06 After-Close 19.78% 23.46% 1.19x Exceeded
2026-03-02 After-Close 15.96% 6.88% 0.43x Within
2026-05-07 After-Close 11.50% 8.92% 0.78x Within
2026-08-06 After-Close 17.43% 4.78% 0.27x Within

Earnings calendar: this week’s reports with expected vs actual moves →

ASTH Options Activity & IV Rank

ASTH IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 77.0%
7-DTE IV: —
Expected Move: $6.60
7-DTE Move: $6.60
Days to Exp: 25 (2026-11-20)

Options Flow

Call Volume: 249
Put Volume: 195
P/C Volume: 0.783
NEUTRAL
Call OI: 6,247
Put OI: 744
P/C OI: 0.119
Total OI: 6,991

ATM Options Pricing

ATM Call: $4.30
ATM Put: $2.30
Call %: 11.5%
Put %: 6.2%

Chain Summary

Chain Volume: 837
Chain OI: 8,402
Last Updated: 10/26/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 50th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
50%
vs own history
GEX tilt
+0.39
OI-weighted, today
Vanna tilt
+0.58
δ-sensitivity to IV
Charm tilt
-0.53
δ-decay vs time
Vanna tilt +0.58: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.53: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 6 ATM contracts, 2k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 26 · No data
30 DTE / 10d —
— pts EXTREME
as of Oct 26 · ATM 83.5% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)78.2HighOct 26
Straddle Price (30 DTE)$6.60Oct 26
Beta Analysis

Risk Metrics

Beta: 0.6266
Alpha: 25.72%
Correlation: 0.1190
R-Squared: 1.4%
Stock Volatility: 67.1%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own ASTH
4 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Millennium Management Hedge fund
Izzy Englander
$8.8M
0.01%
#1663 of 3716+1122.1%13F
Renaissance Technologies Hedge fund
Jim Simons
$3.5M
0.00%
#1653 of 3138-28.6%13F
Citadel Hedge fund
Ken Griffin
$1.2M
0.00%
#3518 of 6285+0.2%13F
Rockefeller Capital Management Family office
Rockefeller family
$243K
0.00%
#2497 of 4729+42.7%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

ASTH Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 49,497,390 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

227 filers36,868,661 shares$1.59B value74.49% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 6,899,990 $320.23M 20.08% 13.94% 2026-06-30
2 Vanguard Portfolio Management LLC 2,605,775 $120.93M 7.58% 5.26% 2026-06-30
3 Vanguard Group Inc Custodian 4,238,192 $105.15M 6.59% 8.56% 2025-12-31
4 Vanguard Capital Management LLC 1,946,431 $90.33M 5.67% 3.93% 2026-06-30
5 State Street Corp 1,738,930 $80.70M 5.06% 3.51% 2026-06-30
6 325 CAPITAL LLC 1,613,843 $74.90M 4.70% 3.26% 2026-06-30
7 Dimensional Fund Advisors LP Custodian 1,468,508 $68.15M 4.27% 2.97% 2026-06-30
8 Wellington Management Group LLP Custodian 1,292,573 $59.99M 3.76% 2.61% 2026-06-30
9 Geode Capital Management, LLC Custodian 1,167,974 $54.22M 3.40% 2.36% 2026-06-30
10 Bank of America Corp Custodian 852,145 $39.55M 2.48% 1.72% 2026-06-30
11 FMR LLC Custodian 685,922 $31.83M 2.00% 1.39% 2026-06-30
12 Wells Fargo & Company Custodian 664,940 $30.86M 1.94% 1.34% 2026-06-30
13 Charles Schwab Investment Management, Inc. 652,669 $30.29M 1.90% 1.32% 2026-06-30
14 Ameriprise Financial, Inc. Custodian 512,110 $23.77M 1.49% 1.03% 2026-06-30
15 Northern Trust Corp Custodian 505,044 $23.44M 1.47% 1.02% 2026-06-30
16 Diamond Hill Capital Management, LLC (Investment Advisor) 475,941 $22.09M 1.39% 0.96% 2026-06-30
17 ROYCE & ASSOCIATES LP 472,480 $21.93M 1.38% 0.95% 2026-06-30
18 Morgan Stanley Custodian 433,508 $20.12M 1.26% 0.88% 2026-06-30
19 Invesco Ltd. Custodian 381,830 $17.72M 1.11% 0.77% 2026-06-30
20 SteelPeak Wealth, LLC 435,144 $15.48M 0.97% 0.88% 2026-09-30
21 Vanguard Fiduciary Trust Co 307,022 $14.25M 0.89% 0.62% 2026-06-30
22 Goldman Sachs Group Inc Custodian 271,798 $12.61M 0.79% 0.55% 2026-06-30
23 Principal Financial Group, Inc. 267,706 $12.42M 0.78% 0.54% 2026-06-30
24 EARNEST PARTNERS LLC 258,991 $12.02M 0.75% 0.52% 2026-06-30
25 HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 249,410 $11.58M 0.73% 0.50% 2026-06-30
5 filers$23.75M notional
# Filer Notional Value % of Total Period
1 IMC-Chicago, LLC Custodian $19.89M 83.74% 2026-06-30
2 PEAK6 LLC $1.72M 7.23% 2026-06-30
3 Citadel Advisors LLC Custodian $1.06M 4.47% 2026-06-30
4 Susquehanna International Group, LLP Custodian $584.77K 2.46% 2026-06-30
5 Jane Street Group, LLC Custodian $496.59K 2.09% 2026-06-30
4 filers$1.92M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $816.82K 42.51% 2026-06-30
2 IMC-Chicago, LLC Custodian $561.56K 29.23% 2026-06-30
3 Citadel Advisors LLC Custodian $468.74K 24.40% 2026-06-30
4 Simplex Trading, LLC Custodian $74.26K 3.86% 2026-06-30

ASTH Insider Trading (Form 4)

Latest: 2026-10-13
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-13 John Vong SVP - Accounting (PAO) Tax (F) −556 $37.55 -$20.9K EDGAR
2026-10-08 Brandon Sim CEO and President Tax (F) −9,889 $37.00 -$365.9K EDGAR
2026-10-08 Thomas S. Lam Director Tax (F) −2,624 $37.00 -$97.1K EDGAR
2026-10-06 Chandan Basho COO and CFO Tax (F) −2,092 $35.88 -$75.1K EDGAR
2026-09-17 John Vong SVP - Accounting (PAO) Tax (F) −96 $38.35 -$3.7K EDGAR
2026-09-09 Brandon Sim CEO and President Tax (F) −7,163 $38.47 -$275.6K EDGAR
2026-09-08 Chandan Basho COO and CFO Tax (F) −1,790 $38.47 -$68.9K EDGAR
2026-09-01 Mitchell W Kitayama Director Disp (D) −8,500 $37.09 -$315.3K EDGAR
2026-08-18 David Schmidt Director Mixed — $21.80 -$671.8K EDGAR
2026-08-11 Glenn Sobotka Disp (D) −11,793 — EDGAR
2026-06-12 Weili Dai Director Award (A) +4,525 — EDGAR
2026-06-12 Matthew Mazdyasni Director Award (A) +4,525 — EDGAR
2026-06-12 Mitchell W Kitayama Director Award (A) +4,991 — EDGAR
2026-06-12 David Schmidt Director Award (A) +4,525 — EDGAR
2026-06-12 John Chiang Director Award (A) +4,525 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

ASTH Insider Holdings

14 insiders · @ $37.23
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Kenneth T. Sim Executive Chairman 6,872,209 $255.85M $0 5 2026-04-08
2 Thomas S. Lam Director 6,595,835 $245.56M $0 9 2026-10-08
3 ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp 10%+ Owner 6,132,802 $228.32M $0 1 2025-02-18
4 Brandon Sim CEO and President 1,487,796 $55.39M $0 9 2026-10-08
5 Dinesh M. Kumar Chief Medical Officer 177,655 $6.61M $0 13 2026-04-03
6 Chandan Basho COO and CFO 155,728 $5.80M $0 16 2026-10-06
7 Linda Dong Director 97,133 $3.62M $0 5 2026-06-12
8 David Schmidt Director 56,019 $2.09M $0 7 2026-08-18
9 Matthew Mazdyasni Director 39,288 $1.46M $0 4 2026-06-12
10 John Chiang Director 35,373 $1.32M $0 6 2026-06-12
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

ASTH Board & Officers

As of SEC filings through Oct 13, 2026

Directors 9

Officers 4

  • Brandon Sim · CEO and President · listed since Apr 2024
  • Chandan Basho · COO and CFO · listed since Apr 2024
  • Kenneth T. Sim · Executive Chairman · listed since Nov 2021
  • John Vong · SVP - Accounting (PAO) · listed since Aug 2026
Changes in the last 10 years (53)
Aug 11, 2026John Vong listed as SVP - Accounting (PAO) (previously Chief Accounting Officer) in SEC filings
Aug 11, 2026Glenn Sobotka reported in an SEC filing no longer being Chief Accounting Officer
May 7, 2026The company announced the departure of Dinesh M. Kumar as Chief Medical Officer in an SEC filing
Mar 26, 2025Glenn Sobotka became Chief Accounting Officer
Sep 11, 2024Thomas S. Lam no longer listed as President and Co-CEO in SEC filings
Apr 23, 2024The company announced the departure of Albert WaiChow Young as Chief Administrative Officer in an SEC filing
Apr 4, 2024Chandan Basho listed as COO and CFO (previously Chief Financial Officer and Chief Strategy Officer) in SEC filings
Apr 4, 2024Brandon Sim listed as CEO and President (previously Co-CEO) in SEC filings
Jan 23, 2024Dinesh M. Kumar became Chief Medical Officer
Nov 16, 2023John Vong listed as Chief Accounting Officer (previously SVP-Chief Accounting Officer) in SEC filings
May 25, 2023Chandan Basho listed as Chief Financial Officer and Chief Strategy Officer (previously Interim Chief Financial Officer) in SEC filings
Feb 2, 2023The company announced the departure of Michael F. Eng from the board in an SEC filing
Nov 30, 2022John Vong became SVP-Chief Accounting Officer
May 5, 2022The company announced the departure of Eric Chin as Chief Financial Officer in an SEC filing
May 5, 2022Chandan Basho became Interim Chief Financial Officer
Jan 12, 2022The company announced the departure of Li Yu from the board in an SEC filing
Dec 31, 2021Weili Dai became a director
Dec 31, 2021J. Lorraine Estradas became a director
Nov 4, 2021Kenneth T. Sim listed as Executive Chairman (previously Executive Chairman and Co-CEO) in SEC filings
Nov 4, 2021Brandon Sim listed as Co-CEO (previously Chief Technology Officer, Interim Co-COO and Vice President of Engineering) in SEC filings
Not reported recently (8)
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
85 ETFs hold ASTH
25 shown · $416.84M total exposure · 0.09% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 IJR iShares Core S&P Small-Cap ETF iShares (BlackRock) 0.09% $93.7M $104.0B 2026-10-23
2 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $50.4M — 2026-09-30
3 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.06% $42.8M $74.6B 2026-10-23
4 VB Vanguard Morningstar Small-Cap ETF Vanguard 0.02% $35.7M — 2026-09-30
5 VBK Vanguard Morningstar Small-Cap Growth ETF Vanguard 0.05% $19.9M — 2026-09-30
6 VXF Vanguard Extended Market ETF Vanguard 0.02% $16.8M — 2026-09-30
7 IWO iShares Russell 2000 Growth ETF iShares (BlackRock) 0.12% $16.0M $13.7B 2026-10-23
8 SPSM State Street® SPDR® Portfolio S&P 600™ Small Cap ETF SPDR (State Street) 0.09% $14.4M $15.8B 2026-10-23
9 DFAS Dimensional US Small Cap ETF Dimensional 0.04% $14.3M — 2026-10-23
10 IJS iShares S&P Small-Cap 600 Value ETF iShares (BlackRock) 0.17% $13.1M $7.7B 2026-10-23
11 DFAT Dimensional US Targeted Value ETF Dimensional 0.04% $11.6M — 2026-10-23
12 DFSV Dimensional US Small Cap Value ETF Dimensional 0.04% $10.0M — 2026-10-23
13 VTWO Vanguard Russell 2000 ETF Vanguard 0.05% $9.4M — 2026-09-30
14 FYC First Trust Small Cap Growth AlphaDEX® Fund First Trust 0.68% $9.0M $1.3B 2026-10-23
15 SLYV State Street® SPDR® S&P 600™ Small Cap Value ETF SPDR (State Street) 0.17% $8.2M $4.8B 2026-10-23
16 SCHA Schwab U.S. Small-Cap ETF Nport 0.03% $7.8M — 2026-05-31
17 FNDA Schwab Fundamental U.S. Small Company ETF Nport 0.08% $6.8M — 2026-05-31
18 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.01% $5.6M — 2026-10-23
19 VIOO Vanguard S&P Small-Cap 600 ETF Vanguard 0.09% $5.3M — 2026-09-30
20 DFMC Dimensional US Micro Cap ETF Dimensional 0.07% $5.2M — 2026-10-23
21 RWJ Invesco S&P SmallCap 600 Revenue ETF Invesco 0.24% $4.9M — 2026-10-24
22 VHT Vanguard Health Care ETF Vanguard 0.02% $4.8M — 2026-09-30
23 FYX First Trust Small Cap Core AlphaDEX® Fund First Trust 0.32% $4.4M $1.4B 2026-10-23
24 XHS State Street® SPDR® S&P® Health Care Services ETF SPDR (State Street) 1.66% $3.7M $221.7M 2026-10-23
25 VIOV Vanguard S&P Small-Cap 600 Value ETF Vanguard 0.17% $3.1M — 2026-09-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$0.82
TTM Revenue
$3.84B
TTM Net Income
$40.55M
TTM Op. Cash Flow
$107.87M
Quarterly figures (10 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$972.52M$19.74M$0.40$32.75M
Q1 '262026-03-31$965.10M$14.44M$0.29$68.06M
Q4 '252025-12-31$950.53M$6.00M$0.13$-2.89M
Q3 '252025-09-30$956.05M$373.00K$0.01$9.96M
Q2 '252025-06-30$654.81M$9.42M$0.19$90.90M
Q1 '252025-03-31$620.39M$6.69M$0.14$16.63M
Q4 '242024-12-31$665.21M$-6.95M$-0.14$-10.95M
Q3 '242024-09-30$478.71M$16.09M$0.33$33.98M
Q2 '242024-06-30$486.26M$19.17M$0.40$23.19M
Q1 '242024-03-31$404.36M$14.84M$0.31$5.98M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-10
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
45.40
P/B
2.19
P/S
0.48
EV/EBITDA
14.22
EV/Sales
0.60
ROE
4.8%
ROA
1.8%
Div Yield
0.10%
FCF Yield
5.85%
Debt/Equity
1.05
Current Ratio
—
Market Cap
$1.84B
as of 2026-10-26
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
3.09M
SI % of Float
6.95%
Days to Cover
5.80
Short Vol Ratio
66.0%
Free Float
44.40M
Float %
79.7%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-08-24